Sartorius Stedim Biotech S.A. (DIM.PA)
EUR 188.3
(1.02%)
EUR 188.3
(1.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 629.7 Million | 612.3 Million | 695.97 Million | 416.87 Million | 310.12 Million | 227.28 Million |
| Net Income | 309.7 Million | 1.13 Billion | 646.72 Million | 482.63 Million | 317.6 Million | 284.54 Million |
| Depreciation & Amortization | 237.6 Million | 181.7 Million | 141.55 Million | 102.28 Million | 73.23 Million | 60.91 Million |
| Deferred income taxes | - | - | -900 Thousand | -879 Thousand | -972 Thousand | - |
| Stock-based compensation | - | - | 900 Thousand | 879 Thousand | 972 Thousand | 743 Thousand |
| Change in working capital | 190.7 Million | -351.3 Million | -145.75 Million | -44.28 Million | -30.23 Million | -35.41 Million |
| Other non-cash items | -108.3 Million | -348.5 Million | 53.45 Million | -123.74 Million | -50.47 Million | -82.76 Million |
| Investing Cash Flow | -2.81 Billion | -957.5 Million | -465.22 Million | -621.11 Million | -184.9 Million | -176.54 Million |
| Investments in PPE | -473.6 Million | -430.6 Million | -323.98 Million | -159.19 Million | -135.97 Million | -176.54 Million |
| Acquisitions | -2.32 Billion | -515.6 Million | -141.67 Million | -470.61 Million | -48.92 Million | - |
| Investment purchases | - | - | -323.98 Million | -159.19 Million | - | - |
| Sales/Maturities of investments | - | - | 323.98 Million | 159.19 Million | - | - |
| Other Investing Activities | -8.2 Million | -11.3 Million | 432 Thousand | 8.69 Million | -1000.00 | 1000.00 |
| Financing Cash Flow | 2.19 Billion | 220.7 Million | -71.71 Million | 234.06 Million | -122.15 Million | -59.59 Million |
| Debt repayment | -2.32 Billion | -174.4 Million | -79.7 Million | -35.32 Million | -60.48 Million | -22.81 Million |
| Dividends payments | -132.69 Million | -116.1 Million | -62.68 Million | -31.34 Million | -52.54 Million | -42.4 Million |
| Common Stock Repurchased | -1.00 | -3.2 Million | - | - | - | - |
| Common Stock Issuance | 1.3 Million | 3.2 Million | - | - | - | - |
| Other Financing Activities | 4.64 Billion | 511.2 Million | 70.67 Million | 300.72 Million | -9.12 Million | 5.62 Million |
| Accounts receivables | 162.1 Million | -65.8 Million | -87.33 Million | -73.88 Million | 3.84 Million | -21.6 Million |
| Accounts payables | 1.00 | 65.8 Million | 87.33 Million | 73.88 Million | -3.84 Million | - |
| Inventory | 131.19 Million | -217.9 Million | -275.4 Million | -117.3 Million | -66 Million | -64.96 Million |
| Other working capital | -102.6 Million | -133.4 Million | 129.64 Million | 73.02 Million | 35.77 Million | 29.55 Million |
| Cash at beginning of period | 107.1 Million | 223.6 Million | 59.76 Million | 28.16 Million | 23.97 Million | 32.55 Million |
| Cash at end of period | 116.6 Million | 107.1 Million | 223.62 Million | 59.76 Million | 27.64 Million | 23.97 Million |
| Capital Expenditure | -473.6 Million | -430.6 Million | -323.98 Million | -159.19 Million | -135.97 Million | -176.54 Million |
| Effect of forex changes on cash | -300 Thousand | 8 Million | 4.83 Million | 1.76 Million | 598 Thousand | 268 Thousand |
| Net cash flow / Change in cash | 9.5 Million | -116.5 Million | 163.86 Million | 31.59 Million | 3.66 Million | -8.57 Million |
| Free Cash Flow | 156.1 Million | 181.7 Million | 371.98 Million | 257.68 Million | 174.15 Million | 50.74 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 35.5 Million | 47.6 Million | 56 Million | 39.8 Million | 309.7 Million | 35.5 Million |
| Depreciation & Amortization | 76.2 Million | 74.5 Million | 70.4 Million | 62.5 Million | 237.6 Million | 76.1 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 90.6 Million | 39.2 Million | -17.3 Million | 163 Million | 190.7 Million | 700 Thousand |
| Other non-cash items | 56.2 Million | 55 Million | 63.6 Million | -32.5 Million | -108.3 Million | -13.9 Million |
| Investing Cash Flow | -70.4 Million | -80.2 Million | -109.2 Million | -105.2 Million | -2.81 Billion | -2.33 Billion |
| Investments in PPE | -70.4 Million | -80.2 Million | -109.2 Million | -102.8 Million | -473.6 Million | -108.9 Million |
| Acquisitions | - | - | - | - | -2.32 Billion | -2.21 Billion |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -70.4 Million | - | - | -2.4 Million | -8.2 Million | -5.8 Million |
| Financing Cash Flow | -159.8 Million | -376.2 Million | 639.8 Million | -110.7 Million | 2.19 Billion | 2.22 Billion |
| Debt repayment | -29.8 Million | -289.3 Million | -551 Million | -112.5 Million | -2.32 Billion | -201.2 Million |
| Dividends payments | - | -67.09 Million | - | - | -132.69 Million | - |
| Common Stock Repurchased | 3.1 Million | -5.9 Million | - | 500 Thousand | -1.00 | 1.6 Million |
| Common Stock Issuance | - | -300 Thousand | 1.19 Billion | 1.3 Million | 1.3 Million | - |
| Other Financing Activities | -133.1 Million | -13.9 Million | -900 Thousand | -101.4 Million | 4.64 Billion | 2.42 Billion |
| Accounts receivables | 25.9 Million | 50.9 Million | -47 Million | 34.5 Million | 162.1 Million | 54 Million |
| Accounts payables | - | - | - | -34.5 Million | 1.00 | -54 Million |
| Inventory | 43.1 Million | 72.5 Million | 16 Million | 99.3 Million | 131.19 Million | 51.7 Million |
| Other working capital | 21.6 Million | -84.2 Million | -33.29 Million | 63.7 Million | -102.6 Million | -51 Million |
| Cash at beginning of period | 454.1 Million | 695.1 Million | 116.6 Million | 99.3 Million | 107.1 Million | 110 Million |
| Cash at end of period | 482.6 Million | 454.1 Million | 695.1 Million | 116.6 Million | 116.6 Million | 99.3 Million |
| Capital Expenditure | -70.4 Million | -80.2 Million | -109.2 Million | -102.8 Million | -473.6 Million | -108.9 Million |
| Effect of forex changes on cash | 200 Thousand | -900 Thousand | -100 Thousand | 400 Thousand | -300 Thousand | -600 Thousand |
| Net cash flow / Change in cash | 28.5 Million | -241 Million | 578.5 Million | 17.3 Million | 9.5 Million | -10.7 Million |
| Free Cash Flow | 188.1 Million | 136.1 Million | -61.3 Million | 130 Million | 156.1 Million | -10.5 Million |
TRICOMFRU
ACTG
7420
SNLK
33637L
ALNEV